World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
14054
World Ranking
3941
National Ranking
101

Steven M. Jones publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven M. Jones sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 81 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Steven M. Jones D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven M. Jones sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Gene
  • Immune system

His primary areas of study are Virology, Virus, Immunology, Ebola virus and Vesicular stomatitis virus. His study ties his expertise on Immune system together with the subject of Virology. His work in the fields of Orthomyxoviridae, Influenza A virus subtype H5N1 and Influenza A virus overlaps with other areas such as Respiratory infection.

Many of his research projects under Immunology are closely connected to Coronavirus with Coronavirus, tying the diverse disciplines of science together. His Ebola virus study integrates concerns from other disciplines, such as Ecology and Highly pathogenic. The various areas that he examines in his Ebolavirus study include Transmission, Viremia, Ebola vaccine and Vector.

His most cited work include:

  • Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus (765 citations)
  • Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus (765 citations)
  • Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses (261 citations)

What are the main themes of his work throughout his whole career to date?

Steven M. Jones focuses on Virology, Ebola virus, Immunology, Virus and Vesicular stomatitis virus. Steven M. Jones works mostly in the field of Virology, limiting it down to concerns involving Monoclonal antibody and, occasionally, Polyclonal antibodies. His Ebola virus research is multidisciplinary, incorporating elements of Microbiology and Vaccination.

His Virus research includes elements of Interferon and Innate immune system. His Vesicular stomatitis virus research focuses on Vector and how it relates to ZMapp and Viremia. His studies deal with areas such as Secondary infection, Influenza A virus subtype H5N1 and Orthomyxoviridae, Influenza A virus as well as Immunity.

He most often published in these fields:

  • Virology (139.39%)
  • Ebola virus (93.94%)
  • Immunology (62.12%)

What were the highlights of his more recent work (between 2009-2017)?

  • Virology (139.39%)
  • Ebola virus (93.94%)
  • Zaire ebolavirus (27.27%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Virology, Ebola virus, Zaire ebolavirus, Immunology and Glycoprotein. His research on Virology focuses in particular on Ebola vaccine. In general Ebola virus study, his work on Ebolavirus often relates to the realm of Materials science and Transmission electron microscopy, thereby connecting several areas of interest.

His studies in Zaire ebolavirus integrate themes in fields like Epitope, Antigen, Vesicular stomatitis virus and Innate immune system. As a part of the same scientific study, Steven M. Jones usually deals with the Immunology, concentrating on Knockout mouse and frequently concerns with Virus, Interferon and Crimean Congo hemorrhagic fever virus. His Glycoprotein study combines topics from a wide range of disciplines, such as Ebola virus infection, Antibody, Monoclonal antibody and Time to death.

Between 2009 and 2017, his most popular works were:

  • Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model (162 citations)
  • Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model (162 citations)
  • Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. (109 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Gene
  • Antibody

His main research concerns Virology, Monoclonal antibody, Antibody, Immunofluorescence and Epitope. With his scientific publications, his incorporates both Virology and Proinflammatory cytokine. His Proinflammatory cytokine research spans across into subjects like Knockout mouse, Virus, Immune system, Immunology and Cytokine storm.

He interconnects Interferon, Pathogenesis and Crimean Congo hemorrhagic fever virus in the investigation of issues within Knockout mouse. His work carried out in the field of Monoclonal antibody brings together such families of science as Vesicular stomatitis virus, Zaire ebolavirus, Glycoprotein and Ebola virus.

Best Publications

  • The Genome Sequence of the SARS-associated Coronavirus

    Marco A. Marra;Steven J. M. Jones;Caroline R. Astell;Robert A. Holt

  • Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

    Darwyn Kobasa;Steven M. Jones;Steven M. Jones;Kyoko Shinya;John C. Kash

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses

    Michael Garbutt;Ryan Liebscher;Victoria Wahl-Jensen;Steven Jones;Steven Jones

  • Ebola virus: from discovery to vaccine

    Heinz Feldmann;Steven Jones;Hans-Dieter Klenk;Hans-Joachim Schnittler

  • Effective post-exposure treatment of Ebola infection.

    Heinz Feldmann;Steven M Jones;Steven M Jones;Kathleen M Daddario-DiCaprio;Kathleen M Daddario-DiCaprio;Joan B Geisbert

  • Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses

    Masayuki Shimojima;Ayato Takada;Hideki Ebihara;Hideki Ebihara;Gabriele Neumann

  • Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model

    Dennis A. Bente;Judie B. Alimonti;Judie B. Alimonti;Wun Ju Shieh;Gaëlle Camus;Gaëlle Camus

  • Molecular determinants of Ebola virus virulence in mice.

    Hideki Ebihara;Ayato Takada;Darwyn Kobasa;Steven Jones;Steven Jones

  • Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Mark G. Lewis;Joan B. Geisbert

  • Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.

    Tsung Hsien Chang;Toru Kubota;Mayumi Matsuoka;Steven Jones

  • Human immune response to a plague vaccine comprising recombinant F1 and V antigens

    E. D. Williamson;H. C. Flick-Smith;C. LeButt;C. A. Rowland

  • Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α

    Ute Ströher;Antonino DiCaro;Yan Li;James E. Strong

  • Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Joan B. Geisbert;Joan B. Geisbert;Douglas S. Reed

  • Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

    Kathleen M Daddario-DiCaprio;Kathleen M Daddario-DiCaprio;Thomas W Geisbert;Thomas W Geisbert;Ute Ströher;Ute Ströher;Joan B Geisbert

  • Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.

    Unknown

  • Mass Spectrometric Characterization of Proteins from the SARS Virus A Preliminary Report

    Oleg Krokhin;Yan Li;Anton Andonov;Heinz Feldmann;Heinz Feldmann

  • Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.

    Gary P. Kobinger;Heinz Feldmann;Heinz Feldmann;Yan Zhi;Gregory Schumer

  • Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Kinola J. N. Williams;Joan B. Geisbert

  • Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

    Unknown

  • Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses

    Xiangguo Qiu;Lisa Fernando;Judie B. Alimonti;Judie B. Alimonti;P. Leno Melito

  • Assessment of a Vesicular Stomatitis Virus-Based Vaccine by Use of the Mouse Model of Ebola Virus Hemorrhagic Fever

    Steven M. Jones;Ute Ströher;Ute Ströher;Lisa Fernando;Xianggou Qiu

Frequent Co-Authors

Heinz Feldmann
Heinz Feldmann National Institutes of Health
Ute Ströher
Ute Ströher Centers for Disease Control and Prevention
Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Joan B. Geisbert
Joan B. Geisbert The University of Texas Medical Branch at Galveston
Friederike Feldmann
Friederike Feldmann National Institutes of Health
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Xiangguo Qiu
Xiangguo Qiu Public Health Agency of Canada
Mike Bray
Mike Bray National Institutes of Health
Yan Li
Yan Li Public Health Agency of Canada
Hideki Ebihara
Hideki Ebihara Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology, related healthcare degrees such as Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs offer excellent career options. Choosing from the best pmhnp programs online ensures strong clinical placement rates, which are crucial for hands-on experience and professional growth.

Affordability is also an important consideration. Many students look for affordable pmhnp programs that provide quality education without excessive financial burden. Balancing cost with program quality can open doors to rewarding positions in healthcare settings focused on immunological or psychiatric care.

Understanding compensation is key when planning your career. The how much do dnps make resource provides useful insights into Doctor of Nursing Practice salaries across states, helping you evaluate potential earnings in advanced practice roles linked to your degree.

Additionally, those currently working as Family Nurse Practitioners might consider specialty shifts. Learning about the fnp to acnp transition opens pathways to acute care nursing, where deep immunology expertise is highly advantageous.

Best Scientists Citing Steven M. Jones

Trending Scientists

Recently Published Articles